JAMES HUNTER: Open Payments
NPI 1336233113 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 27 payments from 12 companies in 2025. Trend: 2023 $2,012 · 2024 $2,100 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| KYOWA KIRIN, INC. | 2 | $145 |
| PFIZER INC. | 5 | $114 |
| Amgen Inc. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| ABBVIE INC. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| UCB, Inc. | 1 | $36 |
| Radius Health, Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
Products named: CRYSVITA, SAPHNELO, XELJANZ, OCTAGAM IMMUNE GLOBULIN (HUMAN), BENLYSTA, SKYRIZI, KRYSTEXXA, Bimzelx.
Industry payments across GA — which companies pay providers there.
